Healthcare tax adviser: exemptions, deductions, and efficient planning

Healthcare taxation: a specialist regime that demands a specialist adviser

The healthcare sector is one of the few where the standard VAT regime does not apply: the VAT exemption on healthcare services fundamentally changes the cost structure and obligations of operators. Understanding which activities are exempt, which are subject to reduced rates, and which attract the standard rate — and managing the pro-rata where mixed activities coexist — is essential to avoid costly errors.

At BMC we combine general tax knowledge with specialist expertise in the healthcare sector. We advise small practices and dental clinics as well as private hospital groups and pharmaceutical companies carrying out clinical research in multiple countries.

VAT on healthcare services: the exemption and its limits

The VAT exemption on healthcare is not absolute. The VAT Act and DGT rulings have defined the scope of the exemption with precision: the therapeutic or diagnostic purpose of the service is the determining criterion. Cosmetic medicine services without a therapeutic purpose, medical assessments carried out for employers, expert reports for litigation, and certificates for non-therapeutic purposes fall outside the exemption.

This has practical implications: if a clinic provides both exempt and taxable services, it must calculate the VAT recovery pro-rata and, in some cases, consider whether the special pro-rata is more advantageous. The analysis must be carried out from the outset and reviewed annually.

Pharmaceutical companies: R&D&I deductions

Pharmaceutical and biotech companies have access to the R&D&I deductions under Article 35 of the Corporate Income Tax Act — among the most generous in the Spanish tax system. Yet few companies optimise them correctly for lack of specialist advice.

We analyse R&D projects, coordinate with technical advisers on activity qualification, manage motivated-report applications to the Ministry of Science, and plan the application of deductions to maximise the tax benefit. Where Corporate Income Tax liability is insufficient, we explore deduction monetisation.

Medical professional companies: remuneration planning

Practising medicine through a professional company raises specific tax issues: the correct classification of the physician-partner’s income (employment income or income from economic activity), director remuneration, dividend taxation, and access to reduced Corporate Income Tax rates for SMEs. The boundary with simulated structures that the AEAT actively challenges must be understood and respected.

Healthcare sector Corporate Income Tax: key deductions and incentives

Beyond R&D, healthcare entities have access to a range of Corporate Income Tax incentives that are frequently underutilised. The capitalisation reserve under Article 25 LIS allows a 10% deduction for increases in net equity retained in a restricted reserve — for a profitable clinic reinvesting profits to expand facilities or buy imaging equipment, this deduction directly reduces the CIT liability. The equalisation reserve under Article 105 LIS adds a further 10% deduction for companies with a turnover below €10 million, creating a combined 20% deduction potential on retained profits.

Training and continuing professional development expenditure is fully deductible under the standard CIT rules. For healthcare entities operating under collective bargaining agreements that include training hours, the formal documentation of training programmes (linked to the Fundación Estatal para la Formación en el Empleo — FUNDAE, formerly TRIPARTITA) can convert training costs into a higher-rate deduction.

Clinics that invest in accredited healthcare technology — advanced imaging, digital pathology systems, robotic surgery equipment — may qualify for accelerated depreciation under the general rules or, if the investment qualifies as R&D-linked, under the free depreciation provisions of Article 35 LIS. The qualification must be documented before the investment is declared in the CIT return.

Selling a clinic or medical practice: tax planning

The sale of a medical practice or clinic is a once-in-a-career transaction for most healthcare professionals, and the tax consequence of structuring it incorrectly can be material. The fundamental choice — asset sale versus share sale — has very different tax consequences depending on whether the seller is an individual or a company, the structure of the goodwill, and whether the transaction involves real estate.

An asset sale by a company attracts VAT on the taxable assets (equipment, consumables) and Transfer Tax (ITP) on real estate. The gain is taxed as ordinary income at the 25% CIT rate. An individual selling assets directly is taxed on the gain under IRPF — real estate gains at savings base rates (19-28%), business asset gains potentially at general rates if there is asset amortisation to recapture.

A share sale is VAT-exempt under Article 20(One)(18) LIVA. The gain is taxed at savings base rates for individuals (19-28% up to €300K, then 28% above) or at 25% CIT for corporate sellers — with the potential application of the Article 21 LIS dividend exemption if the seller holds ≥5% for over one year and the subsidiary is an active business entity.

The structuring decisions must be made before entering negotiations: once heads of terms are signed under an asset structure, renegotiating to a share sale adds complexity and may not be acceptable to the buyer (who often prefers assets to avoid inheriting contingent liabilities). BMC advises on pre-transaction structuring, including whether incorporating a practice before sale adds value.

AEAT inspection priorities in the healthcare sector

The AEAT’s healthcare sector inspection programme focuses on specific risk areas that practitioners should understand. The most frequent triggers for inspection are:

VAT classification errors. Clinics that classify cosmetic medicine services as exempt when they lack a therapeutic purpose — or that fail to apportion input VAT correctly when providing mixed services — generate reassessment risk. The AEAT cross-checks VAT exemption claims against the professional activities declared in the annual Modelo 390 summary.

Medical professional company salary levels. The AEAT’s inspection guidance for professional companies established that the physician-partner’s salary should represent at least the market rate for the services provided. When a physician’s professional income passes through a company but the declared salary is significantly below what the services would cost if procured at arm’s length, the AEAT reassesses the dividend as employment income and levies the IRPF progressive rate plus late-payment interest.

R&D deduction documentation. Pharmaceutical and biotech companies that apply the Article 35 LIS deduction without a motivated report from the Ministry of Science are at risk of reassessment. The AEAT’s technical inspectors have expertise in challenging R&D qualification, and the burden of proof falls on the taxpayer. Motivated reports provide substantive protection.

Cash transactions in dental practices. Dental practices with high volumes of cash payments are a standard AEAT inspection target. From 2021, the €1,000 cash payment limit under the amended Ley 7/2012 applies to all professional transactions, and dental practices that accept payments above this threshold face a fine of 25% of the amount in excess.

International healthcare groups: transfer pricing and treaty issues

For international healthcare groups operating in Spain — often through a Spanish subsidiary or a branch receiving referrals from UK or US parent entities — transfer pricing on management services, licence fees for clinical protocols, and intercompany financing is a compliance obligation. Articles 16 and 18 LIS govern these transactions, and the OECD Transfer Pricing Guidelines require documentation of the arm’s length nature of all intra-group transactions above the materiality thresholds.

UK and US nationals who have relocated to Spain with private healthcare sector employment should be aware of the interaction between their Spanish tax residency and the Article 21 CIT dividend participation exemption (if they hold shares in the employer group) and the treaty treatment of any UK or US pension contributions. Healthcare professionals receiving signing bonuses or intellectual property royalties from clinical research should take advice before receiving these payments to ensure they are received in the most tax-efficient manner given their residency status.

Pharmacies: the complete tax picture

Community pharmacies in Spain have a tax profile that differs from other healthcare entities. Most operate as individual professionals (autónomos) or through a simplified corporate structure, and the annual módulos estimation regime (estimación objetiva) may be available for practices below the revenue thresholds.

Pharmaceutical dispensing applies the 4% super-reduced VAT rate for human medicines authorised by the AEMIB and the 10% reduced rate for other medical devices and products. Para-pharmacy and cosmetic products attract the standard 21% rate, creating mixed-rate management obligations for pharmacies that sell across these categories.

The succession or sale of a pharmacy licence (oficina de farmacia) is a significant tax event. In Spain, pharmacy licences can only be held by qualified pharmacists, which limits the buyer pool and creates specific valuation challenges. The sale of a pharmacy as a business — goodwill, stock, and fixtures — attracts capital gains treatment under IRPF (savings base rates) for the selling pharmacist. Planning the sale structure, the allocation of the purchase price between goodwill and stock, and the interaction with the autonomous community’s Transfer Tax obligations for the licence transfer requires specialist advice.

Healthcare tax compliance calendar

The healthcare sector has specific compliance dates that practitioners must manage alongside the standard Spanish tax calendar. Annual Modelo 390 VAT summary (January 31), Modelo 347 related-party and large transaction declaration (February 28), quarterly Modelo 303 VAT returns (April 20, July 20, October 20, January 20), and the annual Corporate Income Tax return (July 25 for December year-ends) form the core compliance cycle. For clinics with employed staff, monthly Modelo 111 payroll withholding returns add to the obligation list. BMC manages the complete healthcare sector compliance calendar for clients, ensuring all deadlines are met and all relevant sector-specific returns are correctly prepared.